Sunda Energy PLC (AIM:SNDA) has made a transformational acquisition in New Zealand, giving it immediate production of over 1,000 barrels a day. The deal adds a third pillar to its portfolio alongside assets in Timor-Leste and the Philippines. Watch more
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has expanded its partnership with TDK Corporation, successfully moving its battery cathode technology into a pouch cell format. TDK dominates the drone battery market, and prototype results are expected soon. Watch more
Coiled Therapeutics (AIM:COIL) has reported a jump in clinical benefit rate from 40% to 80% for its cancer drug AO-252 after switching to twice-daily dosing. The company now plans combination trials with multiple data readouts expected this year. Watch more
Solvonis Therapeutics PLC (LSE:SVNS) has secured two US patents for its PTSD treatment programme, covering two distinct chemical series. There are around 20 million PTSD sufferers across key markets, and currently no approved treatments exist. Watch more
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) says benefits from its gene therapy trial in dogs have persisted three months after treatment stopped. That durability raises the possibility of a one-time intervention rather than ongoing treatment. Watch more
Rome Resources Plc (AIM:RMR, FRA:33R) has delivered its strongest ever drilling results at its Kalayi tin prospect in the Democratic Republic of Congo, with significantly wider intercepts than previous campaigns. The deposit sits just eight kilometres from a mine producing over 7% of the world's tin. Watch more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.
